651-660 of 822 results for 'consumer data right'

Key considerations for renewable energy developers seeking private capital to fund expansion
Insight 29 Jan 2025

As renewable energy developers look to expand their project pipelines and operational portfolios, many are turning to private capital sources to help fund their expansion plans. ...

A positive result for diagnostic method patents in Australia
Insight 28 Aug 2019

In the highly anticipated decision Sequenom, Inc. v Ariosa Diagnostics, Inc. [2019] FCA 1011, the Federal Court has confirmed that diagnostic methods remain patent-eligible subject matter in Australia … at least for now.  ...

The interim report of the Financial System Inquiry
Insight 15 Jul 2014

The Financial System Inquiry Interim Report was issued today There are few surprises in the options and comments although there are some significant omissions There does not appear to be any push for a significant shift in policy or in the regulation of the financial system There will be adjustments ...

How to prepare for, and execute, a successful exit
Insight 06 May 2024

After a relatively subdued 2023, we are predicting that the rest of 2024 will prove to be the year of the exit, with improving macroeconomic conditions providing the ideal environment for the exit of a number of high-quality assets. ...

Patent term extensions under siege: a new era of challenges for pharmaceutical patentees
Insight 24 Nov 2024

A recent Federal Court decision has struck down a patent term extension granted to Novartis for its blockbuster heart failure drug Entresto. The decision in Novartis AG v Pharmacor Pty Limited follows a recent trend of successful challenges by generic pharmaceutical companies. ...

The mRNA rush
Insight 30 Jun 2022

There is great potential for mRNA technology to revolutionise future vaccines, and treatment of various conditions such as rare genetic disorders, other infectious diseases and even cancer. The enthusiasm for the technology – or the 'mRNA rush' – is reflected by a spike in patent filings over the past five years, and the growing patent portfolios of key mRNA pioneers and market players. ...

Proposed changes to FIRB approval rules
Insight 16 Feb 2022

On 14 February 2022, the Government released proposed changes to the FIRB approval rules, in the form of an exposure draft of the Foreign Acquisitions and Takeovers Amendment Regulations 2022 which would amend the Foreign Acquisitions and Takeovers Regulations 2015. We outline and comment on the changes proposed. ...

Retail banking and responsible lending during COVID-19
Insight 31 May 2020

The sudden and unknown nature of COVID-19 has triggered a global economic shock, and disrupted Australia's economy. As we enter a national state of economic 'hibernation', banks and lenders are grappling with a sudden influx of relief requests from consumer and business customers. ...

Mandatory vaccinations in the workplace: what do employers need to consider?
Insight 20 Sep 2021

In this Insight, our cross-practice experts cover the employment, safety, privacy, regulatory, insurance and liability considerations that confront employers navigating these complex and rapidly changing public health settings. ...

Australia-Hong Kong Free Trade Agreement, draft CDR rules and other developments
Insight 05 Apr 2019

Welcome to our monthly snapshot of regulatory updates and other developments in corporate law We know you are busy so our focus is on capturing key issues ...

Refine